NCT05259280

Observational Study of the Wellinks Solution Impact on Quality of Life and Clinical Outcomes in Patients With COPD

ASPIRE: An Observational Study of the Wellinks Solution Impact on Quality of Life and Clinical Outcomes in Patients With COPD

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 153 (actual)
• Sponsor: Convexity Scientific Inc · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The clinical objectives of this study are to determine whether utilization of the Wellinks COPD Solution can improve quality of life for patients with COPD, can reduce healthcare resource utilization over time, and can improve pulmonary function as measured by connected devices. The nonclinical objectives of this study are to describe the experience of patients using the Wellinks Solution through the assessment of patient engagement with the solution, as well as by patient-reported satisfaction with the solution and their perceived value (e.g., willingness to pay). Qualitative feedback on the features and functionality of the Wellinks Solution will be solicited.

Conditions

• COPD
• Chronic Obstructive Pulmonary Disease
• Chronic Obstructive Pulmonary Disease Severe
• Chronic Obstructive Pulmonary Disease Moderate

Interventions

Type	Name	Description
OTHER	Wellinks	Digital health and virtual care program for COPD management.

Timeline

• Start date: 2022-01-05
• Primary completion: 2022-09-08
• Completion: 2022-09-08
• First posted: 2022-02-28
• Last updated: 2023-11-02

Locations

2 sites across 1 country: United States